Glucosamine: The Joint Supplement That Keeps Showing Up in Longevity Data

The Oasis Health Journal · Submitted June 26, 2026 · 5:17 PM ET

Glucosamine has a strange resume. People take it for their knees. The evidence that it does much for knees is, to put it kindly, a coin flip. And yet every few years another enormous study follows half a million people and quietly notes that the glucosamine takers are dying less. Of everything. It is the supplement version of the guy who wanders into the wrong meeting and somehow gets promoted.

The gap between the knee story and the longevity story is the whole point, so let me walk through both.

The day job: cushioning your knees, allegedly

Cartilage is the bubble wrap between your bones. Glucosamine is one of the raw materials your body uses to build it. The pitch writes itself: swallow the ingredient, build the cushion. Your body did not read the pitch.

The biggest test was the NIH-funded GAIT trial, 1,583 people with knee osteoarthritis, glucosamine versus chondroitin versus both versus the drug celecoxib versus placebo. Overall result: glucosamine did not beat the sugar pill. About 60 percent of the placebo group counted as responders, which is a reminder that knees are suggestible. There was one wrinkle. In the subgroup with moderate to severe pain, glucosamine plus chondroitin did pull ahead, but that group was small and the authors flagged it as preliminary. So glucosamine's report card for joints reads: incomplete, see teacher.

(There is also a long-running argument about which glucosamine. American trials tend to use glucosamine hydrochloride. The more positive European trials used prescription-grade glucosamine sulfate. The molecules are cousins, not twins, which is the kind of detail that keeps meta-analyses messy.)

The plot twist: the longevity data nobody ordered

Here is where it gets odd. Researchers kept mining the UK Biobank, a database of roughly half a million British adults, and glucosamine kept looking good for things that have nothing to do with cartilage.

One analysis of 495,077 people found that regular glucosamine users had about 15 percent lower all-cause mortality over the follow-up, with 18 percent lower cardiovascular death and 27 percent lower respiratory death, after adjusting for the usual suspects (age, smoking, diet, exercise, and the rest). A separate 2019 analysis of 466,039 people found habitual users had lower rates of cardiovascular events overall (around 15 percent lower), plus lower coronary heart disease and fewer deaths from heart disease.

Then came 2025. A propensity-matched study in Aging Clinical and Experimental Research took 269,033 people with no major chronic disease at baseline, paired each glucosamine user with a statistically identical non-user, and followed them for a median of 13.8 years. Regular use was tied to a significantly lower risk of seven separate age-related conditions: heart failure, coronary heart disease, COPD, chronic liver disease, gout, colorectal cancer, and esophageal cancer. Seven. For a knee pill.

Before you buy a barrel of it

Deep breath. Every one of those studies is observational. They show association, not cause. And glucosamine has a famous problem called healthy-user bias: the kind of person who takes a daily joint supplement for years also tends to exercise, skip cigarettes, and actually see a doctor. The pill might be a marker of a tidy life rather than the cause of a long one. Nobody has run the giant multi-year randomized trial that would settle it, so the honest summary is intriguing, oddly consistent across huge datasets, and still unproven. Scientists have floated mechanisms (mild anti-inflammatory effects, a metabolic signal that loosely mimics a low-carb diet), but those are hypotheses wearing lab coats, not verdicts.

Safety-wise, glucosamine is one of the better-behaved supplements. Large reviews turned up no serious harms, with side effects limited to occasional stomach upset, headache, or rash. The fine print that actually matters: most glucosamine is made from shellfish shells, so a shellfish allergy is a real flag. It can nudge up bleeding risk if you take the blood thinner warfarin. And it may raise blood sugar or eye pressure, which is worth a conversation if you live with diabetes or glaucoma. None of that is a scare, it is just a reason to loop in the person who has your chart.

Where we land

Glucosamine is the rare supplement whose side gig (maybe-longevity) is more interesting than its main job (maybe-knees). If you already take it for your joints, the population data is a pleasant bonus. If you are buying it as a longevity moonshot, go in clear-eyed that the evidence is associative, not a guarantee.

If you do take it, potency is the whole game, and potency quietly fades on a warehouse shelf. We make our professional-grade joint support formulas fresh per order instead of aging stock in a stockroom, which makes our shipping a little slower and our actives a little more alive. Worth the wait, in our biased opinion. And the researchers who keep pairing glucosamine with fish oil in their analyses seem to think it travels in good company.

This article is for education only and is not medical advice, diagnosis, or treatment. Talk with a qualified clinician before starting any supplement, especially if you take warfarin, manage diabetes or glaucoma, or have a shellfish allergy.

Sources

1. He J, Ma Y, Jiang Y, et al. Regular glucosamine supplementation and risk of age-related chronic diseases: a propensity score-matched cohort study. Aging Clin Exp Res. 2025
2. Li ZH, et al. Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Ann Rheum Dis. 2020
3. Ma H, et al. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019
4. Clegg DO, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis (GAIT). N Engl J Med. 2006
5. NCCIH. Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know. U.S. National Institutes of Health